• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类脂肪组织中 INSR 的剪接与空腹胰岛素水平相关,并受体重减轻调节。

Adipose tissue INSR splicing in humans associates with fasting insulin level and is regulated by weight loss.

机构信息

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, 70210, Kuopio, Finland.

出版信息

Diabetologia. 2014 Feb;57(2):347-51. doi: 10.1007/s00125-013-3097-4. Epub 2013 Nov 7.

DOI:10.1007/s00125-013-3097-4
PMID:24196191
Abstract

AIMS/HYPOTHESIS: The insulin receptor (INSR) has two protein isoforms based on alternative splicing of exon 11. INSR-A promotes cell growth whereas INSR-B predominantly regulates glucose homeostasis. In this study we investigated whether weight loss regulates INSR alternative splicing and the expression of splicing factors in adipose tissue.

METHODS

To determine the relative ratio of the INSR splice variants, we implemented the PCR-capillary electrophoresis method with adipose tissue samples from two weight-loss-intervention studies, the Kuopio Obesity Surgery study (KOBS, n = 108) and a very low calorie diet (VLCD) intervention (n = 32), and from the population-based Metabolic Syndrome in Men study (METSIM, n = 49).

RESULTS

Expression of INSR-B mRNA variant increased in response to weight loss induced by both bariatric surgery (p = 1 × 10(-5)) and the VLCD (p = 1 × 10(-4)). The adipose tissue expression of INSR-B correlated negatively with fasting insulin levels in the pooled data of the three studies (p = 3 × 10(-22)). Finally, expression of several splicing factors correlated negatively with the expression of the INSR-B variant. The strongest correlation was with HNRNPA1 (p = 1 × 10(-5)), a known regulator of INSR exon 11 splicing.

CONCLUSIONS/INTERPRETATION: INSR splicing is regulated by weight loss and associates with insulin levels. The effect of weight loss on INSR splicing could be mediated by changes in the expression of splicing factors.

摘要

目的/假设:胰岛素受体(INSR)有两种蛋白异构体,基于外显子 11 的选择性剪接。INSR-A 促进细胞生长,而 INSR-B 主要调节葡萄糖稳态。在这项研究中,我们研究了体重减轻是否调节脂肪组织中的 INSR 选择性剪接和剪接因子的表达。

方法

为了确定 INSR 剪接变体的相对比率,我们使用来自两个体重减轻干预研究的脂肪组织样本,即库奥皮奥肥胖手术研究(KOBS,n=108)和极低卡路里饮食(VLCD)干预(n=32),以及来自基于人群的代谢综合征男性研究(METSIM,n=49),实施了 PCR-毛细管电泳法。

结果

两种减重手术(手术组 p=1×10(-5))和极低卡路里饮食(VLCD 组 p=1×10(-4))均可诱导 INSR-B mRNA 变体的表达增加。在这三项研究的汇总数据中,脂肪组织中 INSR-B 的表达与空腹胰岛素水平呈负相关(p=3×10(-22))。最后,几种剪接因子的表达与 INSR-B 变体的表达呈负相关。与 INSR 外显子 11 剪接相关的已知调节因子 HNRNPA1(p=1×10(-5))的相关性最强。

结论/解释:INSR 剪接受体重减轻调节,并与胰岛素水平相关。体重减轻对 INSR 剪接的影响可能是通过剪接因子表达的变化介导的。

相似文献

1
Adipose tissue INSR splicing in humans associates with fasting insulin level and is regulated by weight loss.人类脂肪组织中 INSR 的剪接与空腹胰岛素水平相关,并受体重减轻调节。
Diabetologia. 2014 Feb;57(2):347-51. doi: 10.1007/s00125-013-3097-4. Epub 2013 Nov 7.
2
Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance.肥胖相关的低氧通过 miR-128 降低了人及鼠脂肪组织中胰岛素受体的表达,从而促进了全身胰岛素抵抗。
EBioMedicine. 2020 Sep;59:102912. doi: 10.1016/j.ebiom.2020.102912. Epub 2020 Jul 29.
3
Adipose tissue insulin receptor and glucose transporter 4 expression, and blood glucose and insulin responses during glucose tolerance tests in transition Holstein cows with different body condition.在体况不同的荷斯坦奶牛的葡萄糖耐量试验中,脂肪组织胰岛素受体和葡萄糖转运蛋白 4 的表达以及血糖和胰岛素反应。
J Dairy Sci. 2018 Jan;101(1):752-766. doi: 10.3168/jds.2017-12877. Epub 2017 Nov 6.
4
Regulation of alternative splicing in human obesity loci.人类肥胖相关基因座可变剪接的调控。
Obesity (Silver Spring). 2016 Oct;24(10):2033-7. doi: 10.1002/oby.21587. Epub 2016 Aug 12.
5
Aberrant liver insulin receptor isoform a expression normalises with remission of type 2 diabetes after gastric bypass surgery.胃旁路手术后2型糖尿病缓解时,肝脏中异常的胰岛素受体亚型a表达恢复正常。
PLoS One. 2015 Mar 5;10(3):e0119270. doi: 10.1371/journal.pone.0119270. eCollection 2015.
6
Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity.在肥胖受试者热量限制期间,视黄醇结合蛋白4的血浆水平和脂肪组织信使核糖核酸表达降低,但与饮食诱导的胰岛素敏感性变化无关。
J Clin Endocrinol Metab. 2007 Jun;92(6):2330-5. doi: 10.1210/jc.2006-2668. Epub 2007 Apr 3.
7
Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.1 型和 2 型肌强直性营养不良患者Ⅰ型和Ⅱ型骨骼肌纤维中人胰岛素受体基因(INSR)的可变剪接。
Mol Cell Biochem. 2013 Aug;380(1-2):259-65. doi: 10.1007/s11010-013-1681-z. Epub 2013 May 11.
8
Insulin and Insulin Receptors in Adipose Tissue Development.胰岛素和胰岛素受体在脂肪组织发育中的作用。
Int J Mol Sci. 2019 Feb 11;20(3):759. doi: 10.3390/ijms20030759.
9
Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism.脂肪组织 TCF7L2 剪接受体重减轻调节,并与葡萄糖和脂肪酸代谢相关。
Diabetes. 2012 Nov;61(11):2807-13. doi: 10.2337/db12-0239. Epub 2012 Oct 18.
10
Insulin receptor alternative splicing is regulated by insulin signaling and modulates beta cell survival.胰岛素受体可变剪接受胰岛素信号调控,并调节β细胞存活。
Sci Rep. 2016 Aug 16;6:31222. doi: 10.1038/srep31222.

引用本文的文献

1
Comparative Transcriptomic Analysis Reveals Key Growth-Related Genes and Alternative Splicing Events in Siniperca scherzeri.比较转录组分析揭示了斑鳜关键生长相关基因和可变剪接事件。
Mar Biotechnol (NY). 2025 Sep 11;27(5):137. doi: 10.1007/s10126-025-10516-y.
2
Dynamic Rendition of Adipose Genes Under Epigenetic Regulation: Revealing New Mechanisms of Obesity Occurrence.表观遗传调控下脂肪基因的动态呈现:揭示肥胖发生的新机制
Curr Issues Mol Biol. 2025 Jul 11;47(7):540. doi: 10.3390/cimb47070540.
3
Alternative Splicing Regulation in Metabolic Disorders.

本文引用的文献

1
Adipose tissue TCF7L2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism.脂肪组织 TCF7L2 剪接受体重减轻调节,并与葡萄糖和脂肪酸代谢相关。
Diabetes. 2012 Nov;61(11):2807-13. doi: 10.2337/db12-0239. Epub 2012 Oct 18.
2
Psychobehavioural factors are more strongly associated with successful weight management than predetermined satiety effect or other characteristics of diet.与预先设定的饱腹感效应或饮食的其他特征相比,心理行为因素与成功的体重管理关联更为紧密。
J Obes. 2012;2012:274068. doi: 10.1155/2012/274068. Epub 2012 Jun 25.
3
hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
代谢紊乱中的可变剪接调控
Obes Rev. 2025 May 27:e13950. doi: 10.1111/obr.13950.
4
Modulation of DAPK1 expression by its alternative splice variant DAPK1-215 in cancer.癌症中其可变剪接变体DAPK1-215对DAPK1表达的调控
J Transl Med. 2025 Jan 20;23(1):85. doi: 10.1186/s12967-025-06127-9.
5
Characterization of the regulatory network and pathways in duodenum affecting chicken abdominal fat deposition.影响鸡腹部脂肪沉积的十二指肠调控网络和信号通路的特征分析
Poult Sci. 2024 Dec;103(12):104463. doi: 10.1016/j.psj.2024.104463. Epub 2024 Oct 31.
6
The Anti-Obesogenic Effects of Muscadine Grapes through Ciliary Neurotrophic Factor Receptor (Cntfr) and Histamine Receptor H1 (Hrh1) Genes in 3T3-L1 Differentiated Mouse Cells.麝香葡萄通过睫状神经营养因子受体 (Cntfr) 和组氨酸受体 H1 (Hrh1) 基因对 3T3-L1 分化的小鼠细胞发挥抗肥胖作用。
Nutrients. 2024 Jun 9;16(12):1817. doi: 10.3390/nu16121817.
7
Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance.胰岛素受体亚型与胰岛素样生长因子受体:在细胞信号传导、致癌作用及化疗耐药性中的意义
Int J Mol Sci. 2023 Oct 9;24(19):15006. doi: 10.3390/ijms241915006.
8
Altered splicing factor and alternative splicing events in a mouse model of diet- and polychlorinated biphenyl-induced liver disease.饮食和多氯联苯诱导的肝病小鼠模型中的剪接因子改变和选择性剪接事件。
Environ Toxicol Pharmacol. 2023 Oct;103:104260. doi: 10.1016/j.etap.2023.104260. Epub 2023 Sep 7.
9
State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer's Disease.脑胰岛素抵抗与阿尔茨海默病导致的认知衰退的科学现状
Aging Dis. 2024 Aug 1;15(4):1688-1725. doi: 10.14336/AD.2023.0814.
10
Current Studies on Molecular Mechanisms of Insulin Resistance.胰岛素抵抗的分子机制的当前研究。
J Diabetes Res. 2022 Dec 23;2022:1863429. doi: 10.1155/2022/1863429. eCollection 2022.
hnRNP A1 和 hnRNP F 调节胰岛素受体基因外显子 11 的可变剪接。
PLoS One. 2011;6(11):e27869. doi: 10.1371/journal.pone.0027869. Epub 2011 Nov 23.
4
Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis.剪接因子基因 SFRS10 的表达在人类肥胖中降低,并有助于增强脂肪生成。
Cell Metab. 2011 Aug 3;14(2):208-18. doi: 10.1016/j.cmet.2011.06.007.
5
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.生理与疾病中的胰岛素受体亚型及胰岛素受体/胰岛素样生长因子受体杂交体
Endocr Rev. 2009 Oct;30(6):586-623. doi: 10.1210/er.2008-0047. Epub 2009 Sep 14.
6
Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.Akt2对类Cdc2激酶(Clk/Sty)的调控、丝氨酸/精氨酸丰富(SR)蛋白的磷酸化以及胰岛素诱导的蛋白激酶CβII信使核糖核酸的可变剪接
Endocrinology. 2009 May;150(5):2087-97. doi: 10.1210/en.2008-0818. Epub 2008 Dec 30.
7
Altered insulin receptor messenger ribonucleic acid splicing in liver is associated with deterioration of glucose tolerance in the spontaneously obese and diabetic rhesus monkey: analysis of controversy between monkey and human studies.自发性肥胖和糖尿病恒河猴肝脏中胰岛素受体信使核糖核酸剪接改变与糖耐量恶化相关:猴与人研究争议分析
J Clin Endocrinol Metab. 1996 Apr;81(4):1552-6. doi: 10.1210/jcem.81.4.8636366.
8
Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.高胰岛素血症与自发性肥胖糖尿病恒河猴肌肉中胰岛素受体mRNA剪接改变有关。
J Clin Invest. 1994 Sep;94(3):1289-96. doi: 10.1172/JCI117447.
9
The B isoform of the insulin receptor signals more efficiently than the A isoform in HepG2 cells.
J Biol Chem. 1995 Sep 1;270(35):20816-23. doi: 10.1074/jbc.270.35.20816.
10
Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients.
Biochem Biophys Res Commun. 1991 Dec 31;181(3):1419-24. doi: 10.1016/0006-291x(91)92097-4.